Biological activity of pertussis vaccine preserved with structural analogs of thiomersal
Sánchez Pérez, E.; González Pacheco, M.; Rodríguez González, H.
Salud Publica de Mexico 23(6): 591-596
1981
ISSN/ISBN: 0036-3634 PMID: 7038908 Document Number: 168828
Document emailed within 1 workday
Related Documents
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Fournier, A.; Gagnon, D.; Quirion, R.; Cadieux, A.; Dumont, Y.; Pheng, L.H.; St-Pierre, S. 1994: Conformational and biological studies of neuropeptide Y analogs containing structural alterations Molecular Pharmacology 45(1): 93-101
Kulikov, V.I.; Muzia, G.I. 1996: Biological role of cellular metabolites--structural analogs of platelet activating factor Biokhimiia 61(3): 387-403
Zaĭtsev, E.M.; Krasnoproshina, L.I.; Mertsalova, N.U.; Mazurova, I.K.; Zakharova, N.S. 2011: Serological activity of vaccine and circulating Bordetella pertussis strains Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 78-82
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Reissmann, S.; Paegelow, I.; Arold, H. 1974: Connection between structure and biological activity of new bradykinin analogs Acta Biologica et Medica Germanica 33(1): 77-88
Sobirov, M.M.; Khalikov, S.Kh.; Saidov, S.S.; Kodirov, M.Z.; Zaĭtsev, S.V.; Chichenkov, O.N.; Varfolomeev, S.D. 1994: Synthesis and biological activity of new analogs of beta-casomorphine-5 Bioorganicheskaia Khimiia 20(7): 740-750
Saari Csallany, A.; Draper, H.H. 1971: Synthesis and biological activity of sulfur analogs of a-tocopherol International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 41(3): 368-375
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Brodeur, B.R.; Hamel, J.; Martin, D.; Rondeau, P. 1991: Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide Human Antibodies and Hybridomas 2(4): 194-199
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Ubukata, M.; Osada, H.; Isono, K. 1985: Synthesis and biological activity of nucleoside antibiotics, ascamycin and its amino acid analogs Nucleic Acids Symposium Series 16: 81-83
Derkach, K.V.; Legkodukh, A.S.; Dar'in, D.V.; Shpakov, A.O. 2016: The Stimulating Effect of Thienopyrimidines, the Structural Analogs of Org 43553, on the Activity of Adenylyl Cyclase in the Testes and on the Testosterone Production in Male Rats Tsitologiia 58(8): 602-609